BACK TO MAIN SITE
 
AGING NEWS
Alzheimers
Arthritis
Bone Disease
Cancer
Cholesterol
Diabetes
Erectile Dysfunction
Heart Disease
Liver Disease
Lung Cancer
Parkinsons
Prostate Disease
Strokes
 
ANTIAGING NEWS
Cosmetic Surgery
Environmental
Hormone Therapy
 
WELLNESS NEWS
Fitness & Diet
Mental Wellbeing
Mens Health
Senior Health
Smoking
Womens Health
 
PRODUCT NEWS
FDA Product Alerts
 
TREATMENT NEWS
Cosmetic Surgery
 
EYESIGHT NEWS
HEARING NEWS
DENTISTRY NEWS
RESEARCH NEWS
Alternative Medicine
Clinical Trials
FDA Updates
Stem Cell Research

LATEST NEWS ON PROSTATE CANCER

 

Latest news on research and treatment for diseases and dysfunction of the prostate from Medical News Today.com

GenVec Announces Interim Survival Data In Pivotal Trial Of TNFeradeā„¢ In Locally Advanced Pancreatic Cancer

GenVec, Inc. (Nasdaq:GNVC) announced today top-line results of an interim analysis from its ongoing Phase III Pancreatic Cancer Clinical Trial with TNFeradeā„¢ (PACT) in patients with locally advanced pancreatic cancer. This interim analysis of overall survival, conducted after the 92nd death (one-third of total expected events), was designed to determine whether the study should continue and took place in the time frame originally estimated.
11/20/2008

Genetic Risk Factors May Tailor Prostate Cancer Screening Approaches

Men with a family history of prostate cancer and African-American men are particularly susceptible to the disease, with a twofold to sevenfold increased risk. Assessing risk in these populations has been difficult. "There have been years of effort to try to identify genes and genetic mutations associated with prostate cancer as there are for breast cancer," said Veda N. Giri, M.D.
11/18/2008

Growing Number Of Young Prostate Cancer Patients Need 'sexual Rehabilitation'

Prostate cancer is being detected and treated at an earlier age, resulting in more cases of erectile dysfunction in younger men. While for many this is a temporary setback, for some it can take much longer and others will never recover their former capability. Dr Michael Lowy from Sydney Men's Health, said the result was a growing demand for "sexual rehabilitation" services, an evolving scientific and clinical branch of sexual medicine and urology.
11/18/2008

Significantly Lower PSA Levels Discovered In Men Who Take Aspirin

The use of aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) is significantly associated with lower PSA levels, especially among men with prostate cancer, say researchers at Vanderbilt University. This large analysis known as the Nashville Men's Health Study included 1,277 participants referred to a urologist for a biopsy of their prostate. Approximately 46 percent of the men reported taking an NSAID, mostly aspirin (37 percent of all men).
11/18/2008

Nymox Reports Positive New Results In 59 Week Study Of Drug For Enlarged Prostate

Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to announce positive new results from the Company's most recent study of NX-1207, its drug in development for benign prostatic hyperplasia (BPH). A total of 67 patients and controls in this multi-center U.S. study consisting of 92% of eligible patients were followed for an average of 59 weeks after a single administration of NX-1207. Of the patients given full dose NX-1207, 76.7% required no further treatment compared to 37.
11/17/2008

Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System For Use In Prostate Surgeries

Cardium Therapeutics (Amex: CXM) and its operating unit InnerCool Therapies, Inc., today announced that it has developed a pelvic cooling catheter system called UroCool(TM), which is designed to induce localized cooling during surgery for prostate cancer (radical prostatectomy). The new technology is being applied in collaboration with renowned prostate surgeon, Thomas E. Ahlering, M.D.
11/17/2008

Cancer Treatment May Result In Bone Loss

New cross-Canada study in Journal of Clinical Oncology outlines risks A new cross-Canada study has found that breast and prostate cancer treatment can foster bone loss. In the online edition of the Journal of Clinical Oncology, the scientists explain how loss of bone mass might affect 46,000 people diagnosed with breast and prostate cancer each year* and place them at increased risk for osteoporosis and fractures.
11/16/2008

New Findings Offer Fresh Hope To Men With Prostate Cancer That Has Returned After Attempted Cure

The link between the PSA (prostate-specific antigen) blood test and the detection of prostate cancer is well-established. In new findings released publicly for the first time today, Australian and New Zealand researchers have demonstrated how two serial measures of PSA can be used to accurately predict a patient's prognosis when prostate cancer returns after attempted cure.
11/16/2008

Treatment Of Patients After Failed High Intensity Focused Ultrasound And Radiotherapy For Localized Prostate Cancer

UroToday.com - One of the international leaders in laparoscopic radical prostatectomy, Jens-Uwe Stozenburg from Leipzig, Germany and associates has reported on the use of salvage laparoscopic extra-peritoneal radical prostatectomy (EERPE) following failed high intensity focused ultrasound therapy (HIFU), external beam radiotherapy (ERBT) or brachytherapy.
11/16/2008

Prevalence Of A Tertiary Gleason Grade And Its Impact On Adverse Histopathologic Parameters In A Contemporary Radical Prostatectomy Series

UroToday.com - Almost 40 years ago, Donald F. Gleason pioneered his well acknowledged grading system of prostate adenocarcinoma. In the ensuing years, the reliability of the Gleason system in predicting the outcomes of patients with prostate cancer (PCa) undergoing surgery, radiation therapy or surveillance has been proven in several single and multi-institutional studies. In its original version, the Gleason system considered only the two most predominant Gleason patterns.
11/15/2008

The Influence Of Statin Medications On Prostate-specific Antigen Levels

UroToday.com - According to a report by Dr. Robert J. Hamilton and associates that appears in the November 5, 2008 issue of the Journal of the National Cancer Institute, statin use lowers PSA levels, and as a result may confound the detection of prostate cancer (CaP) in these patients. Statins are lipid-lowering agents in widespread use in the US. Several reports suggest that men on statins have a reduction in the risk of advanced CaP that ranges from 25% to 75%.
11/15/2008

Robotic-Assisted Laparoscopic Radical Prostatectomy: Perioperative Outcomes Of 1500 Cases

UroToday.com - Consistent with a previous series of robotic-assisted laparoscopic radical prostatectomies (RALP) in over 2,500 patients, reported by Menon, et al., Dr. Vipul Patel presented his group's data on 1,500 RALP patients and confirmed the high-quality outcomes of this procedure. In the online version of the Journal of Endourology, Dr. Patel reported on 1,500 men on whom he performed transperitoneal RALP.
11/15/2008

Androgen-Regulated And Highly Tumorigenic Human Prostate Cancer Cell Line Established From A Transplantable Primary CWR22 Tumor

UroToday.com - The molecular mechanisms underlying development of androgen-independent growth of prostate cancer are largely unknown, and no effective therapies for hormone-refractory prostate cancer exist at present.
11/15/2008

Cancer Treatment May Result In Bone Loss - New Cross Canada Study

A new cross-Canada study has found that breast and prostate cancer treatment can foster bone loss. In the online edition of the American Society of Clinical Oncology, the scientists explain how loss of bone mass might affect 46,000 people diagnosed with breast and prostate cancer each year* and place them at increased risk for osteoporosis and fractures. "Our study also looked at possible medications that can reverse or halt bone loss," says Dr.
11/14/2008

European Urology: Relationship Between Prostate Information And LUTS Evident

In the December issue of European Urology, Dr. Curtis Nickel and associates report on the evidence of a relationship between prostate inflammation and lower urinary tract symptoms (LUTS) in men enrolled in the REDUCE trial .
11/10/2008

Learn more about Prostate Hyperplasia and Prostate Cancer and other Age Related Conditions

Return to Top

 

GET LATEST ANTIAGING
PRODUCT NEWS & REVIEWS

Email:
Name:

 
 
 
Articles Archive Blog Forum Shopping Catalogue Site Map Contact Us Antiaging Wellness Latest News Antiaging Article Index Antiaging Wellness Blog Antiaging Wellness Forum Shop For Antiaging & Wellness Products Antiaging Wellness Site Support